<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-224 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-224</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-224</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-11.html">extraction-schema-11</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of proposed or tested mechanisms linking thymoma (thymic epithelial tumors) to autoimmune disease, including defects in thymic negative selection/central tolerance, altered thymic antigen presentation (e.g., AIRE/Fezf2), abnormal thymopoiesis and T-cell repertoire, regulatory T-cell changes, B-cell/antibody phenomena, and clinical/experimental evidence that supports or contradicts these mechanisms.</div>
                <p><strong>Paper ID:</strong> paper-92c23dd78756c3052c9c18b14fe68a0b09051b7d</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/92c23dd78756c3052c9c18b14fe68a0b09051b7d" target="_blank">Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.</a></p>
                <p><strong>Paper Venue:</strong> Journal of Autoimmunity</p>
                <p><strong>Paper TL;DR:</strong> A detailed retrospective analysis from a patient database allowed the clear identification of histological, in particular the presence of GCs, and biological parameters that would facilitate the evaluation of the probability of the MG outcome postoperatively in thymoma patients.</p>
                <p><strong>Cost:</strong> 0.002</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <p class="empty-note">No extracted data.</p>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <p class="empty-note">No potentially relevant new papers extracted.</p>
        </div>

        </div>

    </div>
</body>
</html>